Caladryl, Australia

Quick links

Choose a section

Quick links to important sections

Advertisements

Caladryl, Australia

Advertisements
Advertisements

Treatment option:

Advertisements

Overview of Caladryl, Australia

Quick Facts

Property Description
Active Ingredients Calamine (Zinc Oxide) plus Topical Analgesic/Antihistamine
Form Lotion (liquid suspension, shake well before use)
Pharmacological Class Antipruritic and Skin Protectant
Origin Over-the-Counter (OTC) Medicine
Route Topical (applied to the skin)

What is Caladryl, Australia? (Identity and Class)

Caladryl is an Over-the-Counter (OTC) topical combination medicine classified as an antipruritic, a skin protectant, and a topical analgesic, available as a lotion. It is designed for self-treatment, providing temporary and localized relief from minor skin irritations. Its liquid suspension base allows it to spread easily across the skin's surface and imparts a distinct cooling sensation as the water evaporates.

This specific combination formulation is positioned for consumers seeking enhanced itch relief alongside the traditional soothing properties of a calamine base, making it a solution for managing acute skin discomfort.

What are the Active Ingredients in Caladryl Lotion? (Composition and Action Principle)

Caladryl achieves its dual-action effect through two primary components: Calamine and a complementary anti-itch agent such as Pramoxine Hydrochloride or Diphenhydramine Hydrochloride.

The primary ingredient, Calamine (a compound of Zinc Oxide and Ferric Oxide), functions as a skin protectant. It is recognized for its role in managing pruritus and drying out oozing areas of irritation by forming a protective barrier on the skin.

In addition to the drying action, the complementary agent (such as Pramoxine, a local anaesthetic) contributes a second line of defense. The local anaesthetic works by stopping nerves from sending pain signals, thereby providing targeted numbness to reduce the sensation of pain and persistent itching. This combination is intended to address both the physical irritation and the discomfort it causes.

Regulatory References

  1. Calamine Lotion Label
  2. Pramoxine Information
Advertisements

What side effects are possible with Caladryl, Australia?

Possible Side Effects and Safety Information

The safety profile of Caladryl (Calamine and a topical analgesic, such as Pramoxine or Diphenhydramine) is generally characterized by localized application site reactions and is detailed in governmental regulatory documents, such as those published by the US Food and Drug Administration (FDA).

Documented Adverse Reactions

The most commonly expected effects are categorized under Skin and Subcutaneous Tissue Disorders. These are generally less serious than systemic effects and may include new redness, swelling, burning, stinging, or mild skin irritation at the area where the lotion is applied. The regulatory information does not utilize the standard CIOMS frequency classifications (e.g., 'common,' 'uncommon').

Serious Safety Considerations

A separate class of effects involves Immune System Disorders. These are documented as serious adverse reactions and relate to signs of systemic allergic reactions (hypersensitivity). These severe reactions may manifest as hives, difficulty breathing, or swelling of the face, lips, tongue, or throat. The development of severe pain at the application site is also noted as a condition requiring evaluation.

Population-Specific Constraints

The regulatory labeling includes specific safety considerations for certain populations. For children under 2 years of age, consultation with a health professional is explicitly required prior to use. Similarly, for women who are pregnant or breastfeeding, official documents state that it is unknown whether the medication passes into breast milk or harms an unborn baby, necessitating medical advice before application.

Regulatory Safety Restrictions

The product is strictly for external use only and is formally contraindicated in individuals with known hypersensitivity or allergy to any component, including Calamine or the topical analgesic. The safety profile also emphasizes that the product must not be used in the eyes.

Advertisements

Overdose and Emergency Response

The documented risks of overdose for this topical combination product (Calamine and a systemic anti-itch agent) relate primarily to accidental oral ingestion. Systemic exposure can lead to severe and potentially life-threatening manifestations, mainly linked to the anti-itch component. Documented presentations include Central Nervous System (CNS) effects such as hallucinations, agitation, confusion, and seizures. Anticholinergic symptoms like rapid heartbeat (tachycardia) and urinary retention may also be observed. Regulatory documents list severe outcomes including serious cardiac problems, cardiac arrhythmias, respiratory failure, and death.

Overdose risks are noted to be elevated in pediatric patients, who may experience more pronounced CNS effects. Official guidance mandates specific emergency actions: if overdose is suspected or the product is swallowed, an individual must immediately contact a Poison Control Center. For critical, life-threatening symptoms, such as passing out, a seizure, or collapse, immediate contact with emergency services is required. Management is constrained by the official statement that no specific antidote is known; therefore, treatment is symptomatic and supportive, involving continuous monitoring of vital signs and Electrocardiogram (ECG) assessment.

Advertisements

Therapeutic Uses of Caladryl, Australia

What Caladryl, Australia treats: main uses and benefits

The Caladryl formulation is used in situations involving symptoms related to inflammatory or irritative states, focusing on easing patient discomfort and protecting the affected skin. The product is relevant when supportive symptom management is appropriate across several common dermal issues.

Symptom Relief and Application Contexts

Caladryl is applied across therapeutic domains where short-term symptom management is appropriate, including conditions characterized by periods of heightened symptoms such as rashes from poisonous plants (like poison ivy or oak), insect bites and stings, minor cuts, minor burns, and the irritation associated with sunburn or chickenpox. The product primarily addresses symptom clusters that may become intense or disruptive, specifically focusing on pruritus (itching), minor pain, and the burning sensation associated with acute skin discomfort, and is applied in addressing the oozing and weeping of lesions.

It contributes to improved comfort during periods of heightened symptoms and supports the patient during difficult episodes by easing the overall symptom load.


Quick Fact: Relief for Itching and Oozing The product is commonly used when supportive symptom management is appropriate for conditions that involve a combination of both sensory discomfort (itching/pain) and physical irritation (oozing/weeping).

Regulatory References

  1. DailyMed Label for Calamine/Pramoxine Lotion
Advertisements

Eligibility and Restrictions for Use

Eligibility Map: Who can and cannot use Caladryl — Official Regulatory Information

The eligibility status for Caladryl, a combination topical medicine containing Calamine and a complementary anti-itch agent like Pramoxine HCl, is strictly defined by government regulatory documents.

Category Regulatory Status
Populations for whom use is allowed Adults and children 2 years of age and older [Source: DailyMed].
Populations for whom use is contraindicated Individuals with known allergy or hypersensitivity to Calamine, Pramoxine HCl, or any other product component [Source: DailyMed].
Age-related eligibility rules Children under 2 years of age are formally prohibited from use unless consulting a doctor [Source: DailyMed].
Condition-specific eligibility rules Use is formally prohibited on specific dermal injuries including deep or puncture wounds, animal bites, serious burns, or severely broken or blistered skin [Source: Kaiser Permanente].
Pregnancy and lactation eligibility status Pregnant and breastfeeding individuals are directed to consult a doctor before use [Source: Cleveland Clinic].
Eligibility-context constraints Application must be limited to the affected area and not used on large areas of the body [Source: Kaiser Permanente].

Connection to the overall eligibility profile: The regulatory framework establishes eligibility by setting a clear minimum age threshold and formally excluding application to specific severe or compromised skin conditions. Additionally, official labeling defines use during pregnancy and breastfeeding as conditional, requiring consultation with a health professional.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official regulatory profile for this topical formulation (Calamine and a potential systemic-absorbing antihistamine) is defined by pharmacodynamic constraints related to the systemic effects of the secondary active ingredient, documented in authoritative government sources.

Interaction Classifications

Classification Detail Official Regulatory Documentation Statement
Interaction Severity Classification Contraindicated (with MAOIs); Clinically significant pharmacodynamic interaction.
Regulatory Basis FDA Prescribing Information / DailyMed.

Documented Interaction Constraints

Co-administration with Monoamine Oxidase Inhibitors (MAOIs) is formally contraindicated due to the risk of prolonging and intensifying the anticholinergic effects of the antihistamine component. This restriction is based on the potential for systemic absorption of the active ingredient, as stated in regulatory labeling.

Furthermore, the profile warns of additive Central Nervous System (CNS) depression resulting from co-administration with other CNS Depressants, including sedatives, tranquilizers, and alcohol.

Interacting Product Category Formal Interaction Outcome
Monoamine Oxidase Inhibitors (MAOIs) Intensified Anticholinergic Effects (Contraindicated combination).
CNS Depressants / Alcohol Additive CNS Depression.

These statements establish a necessary regulatory framework for managing combinations that carry a risk of systemic reinforcement of CNS or anticholinergic activity.

Advertisements

Mechanism of Action

Mechanism of Action

The function of this preparation is derived from a dual mechanism involving its two principal components: Calamine (zinc and ferric oxides) and diphenhydramine. Calamine, primarily zinc oxide, acts as a physical barrier and a mild astringent. It precipitates proteins and causes localized tissue coagulation on the outermost dermal layer, thereby modifying the dermal microenvironment and reducing external stimulus penetration.

Diphenhydramine hydrochloride functions as an inverse agonist at the histamine H1 receptor (H1R). By stabilizing the H1R in an inactive conformation, diphenhydramine prevents histamine binding and downstream signaling. The H1R is typically coupled to the Gq protein pathway. Interruption of this primary signal cascade blocks the subsequent activation of phospholipase C and the associated increase in intracellular calcium concentration. The combined physiological consequence is a localized reduction in the histamine-mediated increase of vascular permeability and vasodilation in the targeted tissue.

Advertisements

Dosage and Administration Information

Administration Protocol: General Protocol

Caladryl is a topical combination medicine formulated as a liquid suspension lotion, requiring specific administration procedures. The product is for external use only.


Procedural Requirements

Feature Guideline
Route of Administration Topical (External use only)
Preparation Must be shaken well before using; skin should be cleansed and allowed to dry prior to application.
Frequency and Dosing Applied to the affected area in a thin layer, not exceeding three to four times daily (3-4 times/day).
Course Duration Use is limited to a maximum of seven days. Must be discontinued if symptoms persist beyond this duration.
Age Restriction Approved for use in adults and children 2 years of age and older. Use in children under 2 years requires consultation with a doctor.
Administration Constraints Application must avoid contact with the eyes and mucous membranes.

Connection to the Overall Use Protocol

The standardized instructions establish a protocol that mandates topical administration preceded by the step of shaking the suspension, which ensures delivery of the formulation. This protocol limits the frequency to a maximum of four times daily and imposes a seven-day duration limit, defining the product as a standardized short-term regimen. These procedural details describe the steps for preparation and application, while clarifying the minimum age group for use.

Advertisements

Recent Clinical Evidence

Research evidence / Overview of studies for Caladryl, Australia

The evidence for the Caladryl combination formulation (which includes Calamine/Zinc Oxide and a topical analgesic/antihistamine) is derived from a combination of clinical study designs and regulatory acceptance based on long-standing data, known as monographs. This overview summarizes the types of research that have explored the product's uses, focusing on what outcomes were measured and where research gaps remain, without offering any clinical advice.

Evidence for Symptomatic Pruritus and Minor Skin Irritations

Research for symptoms like itching (pruritus) and minor pain largely involves short-term Randomized Controlled Trials (RCTs), particularly those evaluating the topical analgesic component, and is supported by descriptive studies of the zinc-based components. This research was explored in settings relevant in trials assessing short-term or episodic symptom patterns. The studies monitored patient-reported outcomes describing perceived discomfort and examined short-term symptom changes over defined time intervals.

Study Designs and Measured Outcomes

Researchers generally focused on outcomes related to physical discomfort, monitoring measured changes in symptom severity over defined, short time intervals, often a matter of hours. Studies evaluated the sensory impact of the anti-itch component by measuring changes in itch intensity using patient-reported scales. Studies reported patterns observed in the measured discomfort following application of the anti-itch component during the study period. Because the product is intended for short-term, self-limiting skin irritations, the research provides context for short-term symptom changes but provides limited data regarding long-term effects.

Evidence for Oozing and Weeping Lesions (Skin Protection)

Evidence related to the management of oozing and weeping skin areas focuses on the action of the active component, Zinc Oxide (Calamine), which is regulated as a skin protectant. This evidence is considered High in the context of regulatory acceptance due to its widespread and consistent use cited by regulatory bodies worldwide, including the Therapeutic Goods Administration (TGA).

Regulatory Acceptance and Monograph Data

The regulatory classification of Zinc Oxide was evaluated in various secondary reviews and relies heavily on established data documented in Regulatory Monographs. This research examined outcomes linked to inflammatory or irritative states where topical skin protection is relevant, including changes in erythema (skin redness) and the management of moisture on the skin surface. Research describes the component's relevance to the drying of weeping skin surfaces. The regulatory framework is supported by the long history of use and the component's classification as a physical protective layer.

Long-term Studies and Follow-up Durations

Given that Caladryl is positioned as an over-the-counter medicine for temporary, acute symptom management, research exploring its effects over extended periods is limited. Study designs were intentionally short-term, typically observing responses over a few hours following application or over a few days for minor irritations. There is limited information for long-term outcomes, and long-term effects are not fully established in the research literature, as this kind of data is not typically necessary for a product designed for temporary use.

Key Studies & References

  1. Calamine Lotion (USP) Label Information – DailyMed
  2. Calamine and Pramoxine Hydrochloride Lotion Label Information – DailyMed
  3. Pramoxine topical - MedlinePlus Drug Information
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Caladryl, Australia (FAQ)

Q: Can Caladryl help with the itchiness from mosquito or sandfly bites?

A: Official regulatory documents indicate that Caladryl is formulated for the temporary relief of pain and itching associated with common insect bites. The combination of ingredients is indicated to help soothe the skin and provide temporary relief from the sensation of discomfort caused by these irritations.


Q: Is a slight stinging or burning sensation when applying Caladryl normal?

A: Regulatory adverse reaction profiles indicate that a temporary sensation of burning or stinging at the application site may occur after using the product. If this stinging or burning persists, becomes severe, or is accompanied by signs of a more serious reaction like swelling, it is appropriate to consider discontinuing use.


Q: Can Caladryl cause an allergic reaction on the skin?

A: The potential for an allergic or hypersensitivity reaction exists with any topical medicine. Official warnings state that the user should stop use and consult a health professional if they experience symptoms such as a rash, irritation, or swelling, as these can be signs of an allergic response to a product component.


Q: Why does Caladryl need to be shaken well before use?

A: The product is manufactured as a liquid suspension, meaning the solid active ingredients are mixed into the liquid base. Shaking the bottle well before each use is a mandatory procedural step to ensure the active ingredients, such as Calamine, are evenly distributed throughout the lotion to ensure the product is administered as intended.


Q: Can Caladryl be used on children or infants?

A: Official guidelines state that Caladryl is approved for use in adults and children 2 years of age and older. If the product is being considered for use in a child under 2 years of age, regulatory directions state that consultation with a health professional is required.


Q: Is Caladryl safe to use during pregnancy or while breastfeeding?

A: For individuals who are pregnant or breastfeeding, official regulatory labeling directs that they ask a health professional before using the product. This direction ensures the product is used in alignment with individual health considerations.


Q: Does Caladryl have a cooling effect when applied?

A: The product's liquid base contains water. As the water evaporates from the skin after application, it creates a temporary cooling sensation that helps provide temporary soothing relief from the itch and irritation.


Q: Is Caladryl effective for managing the itch from chickenpox or shingles?

A: The product is indicated for use on itching and to help dry the oozing and weeping associated with rashes. These are symptoms commonly experienced with certain viral skin conditions, and the product is intended for the temporary relief of these specific symptoms.


Q: How does the action of the Calamine in Caladryl differ from the Pramoxine?

A: The product has a dual mechanism of action. Calamine (Zinc Oxide) works as a skin protectant to dry the skin and manage oozing. Pramoxine HCl functions as a topical analgesic (pain reliever) to directly numb the skin and reduce the sensation of pain and itching.


Q: Can Caladryl be used on minor cuts or only intact skin?

A: Regulatory warnings specifically prohibit the use of the product on serious dermal injuries, including deep or puncture wounds and serious burns. The use is not prohibited for minor, non-severe skin breaks, but users should consult the full product warnings regarding skin integrity.


Q: What is the purpose of the 'pink colour' in the Caladryl lotion?

A: The distinctive pink colour comes from Ferric Oxide (iron oxide), which is an essential part of the active ingredient known as Calamine. The colour is simply a characteristic of the formulation.


Q: Does Caladryl actually draw out the venom from insect stings or just soothe the surface?

A: No, the product is not classified as an agent to draw out venom. Instead, it is classified as a skin protectant and topical analgesic. Its purpose is to soothe the surface, relieve symptoms like itching, and help dry the area.


Q: Is Caladryl effective for heat rash or prickly heat?

A: Official indications list the product's use for the temporary relief of pain and itching associated with minor skin irritations. Because heat rash involves minor skin irritation, the product's drying and anti-itch properties can be used for the temporary relief of these symptoms.


Q: Can Caladryl be used on a mild sunburn or only for itching?

A: Regulatory labels for the product list its use for the temporary relief of discomfort associated with minor skin irritations, which specifically includes sunburn. It is intended to soothe the area and provide relief from the associated pain and itching.


Q: What is the 'skin protectant' action of Caladryl?

A: The skin protectant action is provided by the Calamine component, which contains Zinc Oxide. This works by forming a physical barrier on the skin's surface to protect the irritated area and help dry the oozing and weeping that can occur with various rashes.


Q: Does Caladryl dry out the skin significantly after applying it?

A: The product's active ingredient, Calamine, is intended to have a drying action, particularly on oozing or weeping skin. Although this is the intended effect, skin dryness may be reported as a side effect. Discontinuation of use should be considered if the degree of dryness is a concern.


Q: Can Caladryl stain clothing or bedding?

A: The active ingredient Calamine contains Ferric Oxide, which gives the lotion its pink colour. This residue has the potential to stain clothing or bedding, so allowing the product to dry completely before contacting fabrics may help to minimize this potential.


Q: Can I use a moisturiser over or under Caladryl lotion?

A: Official administration instructions require that the skin must be cleansed and dry before the application of Caladryl. Specific instructions regarding the use of other products like moisturizers are not detailed on the regulatory label. Users may wish to consult with a health professional regarding the layering of topical products.


Q: Is Caladryl suitable for sensitive skin types?

A: The product is contraindicated for any individual with a known hypersensitivity or allergy to any of its components. Individuals with sensitive skin should observe the application site, and discontinuation of use is recommended if irritation, rash, or swelling occurs.


Q: Is there any research or evidence that supports Caladryl's effectiveness?

A: Yes, the product’s ingredients are accepted by regulatory bodies and are supported by data established in Regulatory Monographs and short-term clinical studies. This evidence focuses on the management of symptomatic pruritus (itching) and skin protection.


Q: What is the shelf life of an unopened bottle of Caladryl?

A: The shelf life for the product is determined by the manufacturer and is indicated by the expiry date that is printed on the outer carton or on the container itself. The integrity of the product is not assured past this date.


Q: Should I wash the Caladryl off before applying a new layer, or just reapply?

A: Regulatory directions state that the skin should be cleansed and allowed to dry before each new application. This procedure helps ensure the product is applied to a clean surface as directed on the label.


Q: Can Caladryl be used on the face, and are there any areas to specifically avoid?

A: The product is strictly for external use only and must be applied with great care. Official warnings explicitly state that all contact with the eyes and mucous membranes must be avoided.


Q: What should I do if Caladryl accidentally gets into my eye or mouth?

A: The label strictly warns against getting the product into the eyes. If the product is accidentally swallowed, contact a Poison Control Center or seek medical attention.


Q: Is Caladryl considered a topical analgesic or just a skin protectant?

A: Caladryl is classified as a combination product, containing both a Topical Analgesic (Pramoxine HCl) to relieve pain and an Antipruritic/Skin Protectant (Calamine) to soothe and dry the skin.


Q: Can swimming or showering immediately after applying Caladryl reduce its effect?

A: Since this is a topical product designed to remain on the skin, washing the area immediately after application is likely to reduce its effectiveness by removing the active ingredients before they can fully act on the skin.


Q: Is it normal for the Caladryl to feel powdery once it has dried on the skin?

A: Yes, the active ingredient Calamine contains Zinc Oxide. When the liquid portion of the lotion evaporates, the remaining Zinc Oxide forms a physical, dry, and protective layer on the skin's surface, which is expected to feel powdery.


Q: Is Caladryl known to interact with any common antiseptic washes or creams?

A: No specific interaction with antiseptic washes is formally listed in regulatory documents. However, users may wish to consult a health professional before using other topical products on the same area to ensure compatibility.


Q: Does the presence of alcohol in the inactive ingredients have any specific function?

A: Inactive ingredients like SD Alcohol are commonly included in liquid topical formulations. The alcohol acts as a solvent to help the product spread easily and contributes to the rapid evaporation and cooling sensation when applied to the skin.


Q: Does the drying effect of Caladryl help prevent secondary skin infections?

A: The skin protectant and drying action of the Calamine component can assist in the management of oozing or weeping lesions. By helping to dry these areas, it contributes to the management of these areas by creating a dry skin environment.


Q: Can Caladryl be used in combination with an oral antihistamine tablet?

A: The topical antihistamine component has a potential risk of systemic absorption. Due to the potential for additive effects, particularly with other CNS depressants (which can include some oral antihistamines), it is important that the combination be discussed with a health professional.


Q: What is the minimum age limit for using Caladryl on a child?

A: The minimum age for the use of Caladryl without consulting a doctor is 2 years of age. For children younger than this, regulatory guidelines require that medical advice be sought prior to application.

Advertisements

How should Caladryl, Australia be stored and disposed of?

Storage and Disposal of Caladryl Lotion

The official storage and disposal requirements for Caladryl-type topical preparations are regulated to maintain product stability and ensure public safety.

Requirement Official Statement (Australian/International Regulatory Sources)
Storage Temperature The product must be stored below 30 C and kept away from excess heat and moisture [1.2, 2.1].
Handling / Container Must be stored in the original container, tightly closed, and shaken well before use [1.1, 1.2].
Child Safety The medicine must be kept out of reach of children [1.1, 1.2].
Disposal Method Unwanted or expired product must be returned to a community pharmacy for disposal via the Return Unwanted Medicines (RUM) Scheme [2.1, 4.5].
Environmental Rule Do not pour the medicine down the sink or flush down the toilet; disposal via RUM ensures destruction through high-temperature incineration [2.5, 4.5].

These requirements define the necessary conditions for storing the product at room temperature and protecting it from environmental extremes. The disposal mandate ensures the medication is safely processed as pharmaceutical waste by the government-funded RUM Scheme, preventing environmental contamination.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Caladryl, Australia found in:

A-Z Index: